Holen Sie sich die Stockscreener-App
1.28
36.46%
0.342
Finanzdaten der Xilio Therapeutics Inc-Aktie (XLO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
3.55%
17.49
|
18.13 | 17.36 | 20.12 | 23.53 |
| Operating Income/Loss |
3.55%
-17.49
|
-18.13 | -17.36 | -20.12 | -23.53 |
| Nonoperating Income/Loss |
40.21%
0.284
|
0.475 | 0.613 | 0.761 | 0.88 |
| Income/Loss From Continuing Operations Before Tax |
2.56%
-17.20
|
-17.66 | -16.75 | -19.36 | -22.65 |
| Income/Loss From Continuing Operations After Tax |
2.56%
-17.20
|
-17.66 | -16.75 | -19.36 | -22.65 |
|
Net Income/Loss
|
2.56%
-17.20
|
-17.66 | -16.75 | -19.36 | -22.65 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
135.87K%
27.91
|
0.0205 | 27.52 | 27.47 | 27.43 |
| Basic Earnings Per Share |
3.12%
-0.62
|
-0.64 | -0.61 | -0.70 | -0.83 |
| Diluted Earnings Per Share |
3.12%
-0.62
|
-0.64 | -0.61 | -0.70 | -0.83 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):